Scientist - Characterisation
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease. We are developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs.
It is an exciting time to join Immunocore. Our most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies. The company also recently completed its Initial Public Offering and was listed on the NASDAQ.
- Do you enjoy carrying out biochemical characterisation, chemical stability and comparability studies of biologics/drug products.
- Are you passionate about contributing to development of characterisation methods, including peptide mapping – mass spectrometry (LC-MS/MS) and intact mass analysis methods?
- Are you interested in supporting drug substance and drug product impurity characterisation and identification?
- Are you keen to contribute to protein sequence and post translational modification identification of glycosylated and other drug molecules?
If the answer is a big YES! to all of the above, then we are keen to receive you application for this key role in our business!
You must possess a BSc. or MSc. in biochemistry, analytical chemistry, molecular biology or related discipline and have a real passion for the Biotech industry.
Please submit you application now to our growing organisation.